An unwanted guest: Neisseria meningitidis – carriage, risk for invasive disease and the impact of vaccination with insight on Italy incidence

References

• Weichselbaum A. Ueber die Aetiologie der akuten Meningitis cerebrospinalis. Fortschr Med. 1887;5:573–583.
   Google Scholar
• Giardina PC, Weiss JA, Gibson BW, et al. Isolation and analysis of radiolabeled meningococcal endotoxin. Methods Mol Med. 2001;67:441–458.
   PubMedGoogle Scholar
• Rouphael NG, Stephens DS. Neisseria meningitidis: biology, microbiology, and epidemiology. Methods Mol Biol. 2012;799:1–20.
   PubMedGoogle Scholar
• Laver JR, Hughes SE, Read RC. Neisserial molecular adaptations to the nasopharyngeal niche. Adv Microb Physiol. 2015;66:323–355.
   PubMed Web of Science ®Google Scholar
• Gabutti G, Stefanati A, Kuhdari P. Epidemiology of Neisseria meningitidis infections: case distribution by age and relevance of carriage. J Prev Med Hyg. 2015;56(3):E116–20.
   PubMedGoogle Scholar
• Griffiss JM, Brandt B, Jarvis GA. Natural immunity to Neisseria meningitidis. In: Vedros NA, editor. Evolution of meningococcal disease. Vol. II. Boca Raton: CRC Press; 1987. p. 99–119.
   Google Scholar
• Bosis S, Mayer A, Esposito S. Meningococcal disease in childhood: epidemiology, clinical features and prevention. J Prev Med Hyg. 2015;56(3):E121–4.
   PubMedGoogle Scholar
• Read RC. Neisseria meningitidis; clones, carriage, and disease. Clin Microbiol Infect. 2014;20(5):391–395.
   PubMed Web of Science ®Google Scholar
• NNDSS Annual Report Writing Group, Milton A, Stirzaker S, et al. NNDSS Annual Report Writing Group. Australia’s notifiable disease status, 2010: annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell Q Rep 2012;36(1):1–69.
   PubMedGoogle Scholar
• Guarner J, Paddock CD, Bartlett J, et al. Adrenal gland hemorrhage in patients with fatal bacterial infections. Mod Pathol. 2008;21(9):1113–1120.
   PubMed Web of Science ®Google Scholar
• Ladhani SN, Lucidarme J, Newbold LS, et al. Invasive meningococcal capsular group Y disease, England and Wales, 2007-2009. Emerg Infect Dis. 2012;18(1):63–70.
   PubMed Web of Science ®Google Scholar
• Sadarangani M, Scheifele DW, Halperin SA, et al. Outcomes of invasive meningococcal disease in adults and children in Canada between 2002 and 2011: a prospective cohort study. Clin Infect Dis. 2015;60(8):e27–35.
   PubMed Web of Science ®Google Scholar
• Lucas MJ, Brouwer MC, van de Beek D. Neurological sequelae of bacterial meningitis. J Infect. 2016;73(1):18–27.
   PubMed Web of Science ®Google Scholar
• Stephens DS, Greenwood B, Brandtzaeg P. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet. 2007;369(9580):2196–2210.
   PubMed Web of Science ®Google Scholar
• Pizza M, Rappuoli R. Neisseria meningitidis: pathogenesis and immunity. Curr Opin Microbiol. 2015;23:68–72.
   PubMed Web of Science ®Google Scholar
• Sabatini C, Bosis S, Semino M, et al. Clinical presentation of meningococcal disease in childhood. J Prev Med Hyg. 2012;53(2):116–119.
   PubMedGoogle Scholar
• Azzari C, Nieddu F, Moriondo M, et al. Underestimation of invasive meningococcal disease in Italy. Emerg Infect Dis. 2016;22(3):469–475.
   PubMed Web of Science ®Google Scholar
• Cullinan TR, Pieterick C. Packaged treatment for first-line care in cerebral malaria and meningitis. Bull World Health Organ. 1998;76(3):257–264.
   PubMed Web of Science ®Google Scholar
• Brandtzaeg P. Pathogenesis and Pathophysiology of Invasive Meningococcal Disease, in Handbook of Meningococcal Disease: Infection Biology, Vaccination, Clinical Management (eds M. Frosch and M. C. J. Maiden), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, FRG, 2006, p. 427-479.
   Google Scholar
• Thompson MJ, Ninis N, Perera R, et al. Clinical recognition of meningococcal disease in children and adolescents. Lancet. 2006;367(9508):397–403.
   PubMed Web of Science ®Google Scholar
• Miner JR, Heegaard W, Mapes A, et al. Presentation, time to antibiotics, and mortality of patients with bacterial meningitis at an urban county medical center. J Emerg Med. 2001;21(4):387–392.
   PubMed Web of Science ®Google Scholar
• Gianchecchi E, Torelli A, Piccini G, et al. Neisseria meningitidis infection: who, when and where? Expert Rev Anti Infect Ther. 2015;13(10):1249–1263.
   PubMed Web of Science ®Google Scholar
• Jacobs JH, Viboud C, Tchetgen ET, et al. The association of meningococcal disease with influenza in the United States, 1989-2009. PLoS One. 2014 29;9(9):e107486.
   PubMed Web of Science ®Google Scholar
• Molesworth AM, Thomson MC, Connor SJ, et al. Where is the meningitis belt? Defining an area at risk of epidemic meningitis in Africa. Trans R Soc Trop Med Hyg. 2002;96(3):242–249.
   PubMed Web of Science ®Google Scholar
• Jafri RZ, Ali A, Messonnier NE, et al. Global epidemiology of invasive meningococcal disease. Popul Health Metr. 2013;11(1):17.
   PubMed Web of Science ®Google Scholar
• Harrison OB, Claus H, Jiang Y, et al. Description and nomenclature of Neisseria meningitidis capsule locus. Emerg Infect Dis. 2013;19:566–573.
   PubMed Web of Science ®Google Scholar
• Halperin SA, Bettinger JA, Greenwood B, et al. The changing and dynamic epidemiology of meningococcal disease. Vaccine. 2012;30(Suppl 2):B26–36.
   PubMed Web of Science ®Google Scholar
• Taha MK, Achtman M, Alonso JM, et al. Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet. 2000;356(2000):2159.
   PubMed Web of Science ®Google Scholar
• Johannes E, Dag H, Heike C, et al. Spatiotemporal analysis of invasive meningococcal disease, Germany. Emerg Infect Dis. 2006;12(11):1689–1695.
   PubMed Web of Science ®Google Scholar
• Bröker M, Emonet S, Fazio C, et al. Meningococcal serogroup Y disease in Europe: continuation of high importance in some European regions in 2013. Hum Vaccin Immunother. 2015;11(9):2281–2286.
   PubMed Web of Science ®Google Scholar
• Ladhani S, Beebeejaun K, Lucidarme J, et al. Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in England and Wales. Clin Infect Dis. 2015;60:578–585.
   PubMed Web of Science ®Google Scholar
• Bröker M, Bukovski S, Culic D, et al. Meningococcal serogroup Y emergence in Europe: high importance in some European regions in 2012. Hum Vaccin Immunother. 2014;10(6):1725–1728.
   PubMed Web of Science ®Google Scholar
• Törös B, Thulin Hedberg S, Jacobsson S, et al. Surveillance of invasive Neisseria meningitidis with a serogroup Y update, Sweden 2010 to 2012. Euro Surveill. 2014;19:42.
   Google Scholar
• Törös B, Hedberg ST, Unemo M, et al. Genome-based characterization of emergent invasive Neisseria meningitidis serogroup Y isolates in Sweden from 1995 to 2012. J Clin Microbiol. 2015;53(7):2154–2162.
   PubMed Web of Science ®Google Scholar
• Campbell H, Parikh SR, Borrow R, et al. Presentation with gastrointestinal symptoms and high case fatality associated with group W meningococcal disease (MenW) in teenagers, England, July 2015 to January 2016. Eurosurveillance. 2016;12:30175.
   Web of Science ®Google Scholar
• Caugant DA, Mocca LF, Frasch CE, et al. Genetic structure of Neisseria meningitidis populations in relation to serogroup, serotype, and outer membrane protein pattern. J Bacteriol. 1987;169:2781–2792.
   PubMed Web of Science ®Google Scholar
• Maiden MCJ, Bygraves JA, Feil E, et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci USA. 1998;95:3140–3145.
   PubMed Web of Science ®Google Scholar
• Caugant DA, Frøholm LO, Bovre K, et al. Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease. Proc Natl Acad Sci USA. 1986;83:4927–4931.
   PubMed Web of Science ®Google Scholar
• Urwin R, Maiden MC. Multi-locus sequence typing: a tool for global epidemiology. Trends Microbiol. 2003;11:479–487.
   PubMed Web of Science ®Google Scholar
• Maiden MC. Multilocus sequence typing of bacteria. Annu Rev Microbiol. 2006;60:561–588.
   PubMed Web of Science ®Google Scholar
• Bennett J, Watkins E, Jolley K, et al. Identifying Neisseria species by use of the 50s ribosomal protein L6 (rplF) Gene. J Clin Microbiol. 2014;52:1375–1381.
   PubMed Web of Science ®Google Scholar
• Yazdankhah SP, Kriz P, Tzanakaki G, et al. Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway. J Clin Microbiol. 2004;42:5146–5153.
   PubMed Web of Science ®Google Scholar
• Urwin R, Russell JE, Thompson EA, et al. Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design. Infect Immun. 2004;72:5955–5962.
   PubMed Web of Science ®Google Scholar
• Ibarz-Pav_on AB, Maclennan J, Andrews NJ, et al. Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during vaccine implementation. J Infect Dis. 2011;204:1046–1053.
   PubMed Web of Science ®Google Scholar
• Zhou J, Spratt BG. Sequence diversity within the argF, fbp and recA genes of natural isolates of Neisseria meningitidis: interspecies recombination within the argF gene. Mol Microbiol. 1992;6:2135–2146.
   PubMed Web of Science ®Google Scholar
• Lamelas A, Harris SR, Röltgen K, et al. Emergence of a new epidemic Neisseria meningitidis serogroup A Clone in the African meningitis belt: high-resolution picture of genomic changes that mediate immune evasion. MBio. 2014;5(5):e01974–14.
   PubMed Web of Science ®Google Scholar
• Schoen C, Blom J, Claus H, et al. Whole-genome comparison of disease and carriage strains provides insights into virulence evolution in Neisseria meningitidis. Proc Natl Acad Sci U S A. 2008;105(9):3473–3478.
   PubMed Web of Science ®Google Scholar
• Joseph B, Schwarz RF, Linke B, et al. Virulence evolution of the human pathogen Neisseria meningitidis by recombination in the core and accessory genome. PLoS One. 2011;6(4):e18441.
   PubMed Web of Science ®Google Scholar
• Holmes EC, Urwin R, Maiden MC. The influence of recombination on the population structure and evolution of the human pathogen Neisseria meningitidis. Mol Biol Evol. 1999;16:741–749.
   PubMed Web of Science ®Google Scholar
• Jolley KA, Kalmusova J, Feil EJ, et al. Carried meningococci in the Czech Republic: a diverse recombining population. J Clin Microbiol. 2000;38:4492–4498.
   PubMed Web of Science ®Google Scholar
• Mulhall RM, Brehony C, O’Connor L, et al. Resolution of a protracted serogroup B meningococcal outbreak with whole genome sequencing shows inter species genetic transfer. J Clin Microbiol. 2016;54(12):2891-2899.
   Google Scholar
• van Deuren M, Brandtzaeg P, van der Meer JW. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev. 2000;13(1):144–166.
   PubMed Web of Science ®Google Scholar
• Gianchecchi E, Torelli A, Piccini G, et al. N. meningitidis and TLR polymorphisms: a fascinating immunomodulatory network. Vaccines. 2016;4(2):20.
   Web of Science ®Google Scholar
• Guzzetta G, Manfredi P, Gasparini R, et al. On the relationship between meningococcal transmission dynamics and disease: remarks on humoral immunity. Vaccine. 2009;27:3429–3434.
   PubMed Web of Science ®Google Scholar
• Evans CM, Pratt CB, Matheson M, et al. Nasopharyngeal colonization by Neisseria lactamica and induction of protective immunity against Neisseria meningitidis. Clin Infect Dis. 2011;52(1):70–77.
   PubMed Web of Science ®Google Scholar
• Deasy AM, Guccione E, Dale AP, et al. Nasal inoculation of the commensal Neisseria lactamica inhibits carriage of Neisseria meningitidis by young adults: a controlled human infection study. Clin Infect Dis. 2015;60(10):1512–1520.
   PubMed Web of Science ®Google Scholar
• Read RC, Baxter D, Chadwick DR, et al. Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial. Lancet. 2014;384:2123–2131.
   PubMed Web of Science ®Google Scholar
• Glitza IC, Ehrhard I, Müller-Pebody B, et al. Longitudinal study of meningococcal carrier rates in teenagers. Int J Hyg Environ Health. 2008;211:263–272.
   PubMed Web of Science ®Google Scholar
• Caugant DA, Kristiansen BE, Frøholm LO, et al. Clonal diversity of Neisseria meningitidis from a population of asymptomatic carriers. Infect Immun. 1988;56:2060–2068.
   PubMed Web of Science ®Google Scholar
• Brehony C, Jolley KA, Maiden MC. Multilocus sequence typing for global surveillance of meningococcal disease. FEMS Microbiol Rev. 2007;31:15–26.
   PubMed Web of Science ®Google Scholar
• Caugant DA, Tzanakaki G, Kriz P. Lessons from meningococcal carriage studies. FEMS Microbiol Rev. 2007;31:52–63.
   PubMed Web of Science ®Google Scholar
• Beddek AJ, Li MS, Kroll JS, et al. Evidence for capsule switching between carried and disease-causing Neisseria meningitidis strains. Infect Immun. 2009;77(7):2989–2994.
   PubMed Web of Science ®Google Scholar
• Hao W, Ma JH, Warren K, et al. Extensive genomic variation within clonal complexes of Neisseria meningitidis. Genome Biol Evol. 2011;3:1406–1418.
   PubMed Web of Science ®Google Scholar
• Christensen H, May M, Bowen L, et al. Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10:853–861.
   PubMed Web of Science ®Google Scholar
• Soriano-Gabarró M, Wolter J, Hogea C, et al. Carriage of Neisseria meningitidis in Europe: a review of studies undertaken in the region. Expert Rev Anti Infect Ther. 2011;9:761–774.
   PubMed Web of Science ®Google Scholar
• Gasparini R, Comanducci M, Amicizia D, et al. Molecular and serological diversity of Neisseria meningitidis carrier strains isolated from Italian students aged 14 to 22 years. J Clin Microbiol. 2014;52:1901–1910.
   PubMed Web of Science ®Google Scholar
• MenAfriCar consortium. The diversity of meningococcal carriage across the African meningitis belt and the impact of vaccination with a group A meningococcal conjugate vaccine. J Infect Dis. 2015;212(8):1298–1307.
   PubMed Web of Science ®Google Scholar
• Daugla DM, Gami JP, Gamougam K, et al. Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study. Lancet. 2014;383(9911):40–47.
   PubMed Web of Science ®Google Scholar
• Caugant DA, Maiden MC. Meningococcal carriage and disease–population biology and evolution. Vaccine. 2009;27(Suppl 2):B64–70.
   PubMed Web of Science ®Google Scholar
• Cao S, Yang C, Gan Y, et al. The health effects of passive smoking: an overview of systematic reviews based on observational epidemiological evidence. Plos One. 2015;10(10):e0139907.
   PubMed Web of Science ®Google Scholar
• MacLennan J, Kafatos G, Neal K, et al. Social behavior and meningococcal carriage in British teenagers. Emerg Infect Dis. 2006;12(6):950–957.
   PubMed Web of Science ®Google Scholar
• Munford RS, Souza De Morais J, De EA, et al. Spread of meningococcal infection within households. Lancet. 1974;303(7869):1275–1278.
   Google Scholar
• De Wals P, Hertoghe L, Borlée-Grimée I, et al. Meningococcal disease in Belgium. Secondary attack rate among household, day-care nursery and pre-elementary school contacts. J Infect. 1981;3(1):53–61.
   PubMed Web of Science ®Google Scholar
• Hastings L, Stuart J, Andrews N, et al. A retrospective survey of clusters of meningococcal disease in England and Wales, 1993 to 1995: estimated risks of further cases in household and educational settings. Commun Dis Rep CDR Rev. 1997;7(13):R195–200.
   PubMedGoogle Scholar
• European Centre for Disease Prevention and Control (ECDC). Public health management of sporadic cases of invasive meningococcal disease and their contacts. Stockholm: ECDC; 2010. Available from http://ecdc.europa.eu/en/publications/Publications/1010_GUI_Meningococcal_guidance.pdf
   Google Scholar
• Vygen S, Hellenbrand W, Stefanoff P, et al. European public health policies for managing contacts of invasive meningococcal disease cases better harmonised in 2013 than in 2007. Euro Surveill. 2016;21(5):23–31.
   PubMedGoogle Scholar
• Hadjichristodoulou C, Mpalaouras G, Vasilopoulou V, et al. A case-control study on the risk factors for meningococcal disease among children in Greece. PLoS One. 2016;11(6):e0158524.
   PubMed Web of Science ®Google Scholar
• Jansen AG, Sanders EA, VAN DER Ende A, et al. Invasive pneumococcal and meningococcal disease: association with influenza virus and respiratory syncytial virus activity? Epidemiol Infect. 2008;136(11):1448–1454.
   PubMed Web of Science ®Google Scholar
• Castro-Rodriguez JA, Jakubson L, Padilla O, et al. Many respiratory viruses have temporal association with meningococcal disease. Allergol Immunopathol (Madr). 2015;43(5):487–492.
   PubMed Web of Science ®Google Scholar
• Tuite AR, Kinlin LM, Kuster SP, et al. Respiratory virus infection and risk of invasive meningococcal disease in central Ontario, Canada. PLoS One. 2010;5(11):e15493.
   PubMed Web of Science ®Google Scholar
• Cleary PR, Calvert N, Gee S, et al. Variations in Neisseria meningitidis carriage by socioeconomic status: a cross-sectional study. J Public Health (Oxf). 2016;38(1):61–70.
   PubMed Web of Science ®Google Scholar
• Vescio F, Busani L, Mughini Gras L, et al. Climate, demographic factors and geographical variations in the incidence of invasive meningococcal disease in Italy. Epidemiol Infect. 2015;143:1742–1750.
   PubMed Web of Science ®Google Scholar
• Sice A, Robin E, Brochil L. Considération épidémiologiques sur la méningite cérébro-spinale au soudan français. Bulletin De La Société De Pathologie Exotique. 1940;35–59.
   Google Scholar
• Paireau J, Chen A, Broutin H, et al. Seasonal dynamics of bacterial meningitis: a time-series analysis. Lancet Glob Health. 2016;4:e370–7.
   PubMed Web of Science ®Google Scholar
• Greenwood B. Manson Lecture. Meningococcal meningitis in Africa. Trans R Soc Trop Med Hyg. 1999;93:341–353.
   PubMed Web of Science ®Google Scholar
• Lindsay AP, Hope V, Marshall RJ, et al. Meningococcal disease and meteorological conditions in Auckland, New Zealand. Aust N Z J Public Health. 2002;26:212–218.
   PubMed Web of Science ®Google Scholar
• Sultan B, Labadi K, Guégan J-F, et al. Climate drives the meningitis epidemics onset in west Africa. Plos Med. 2005;2:e6.
   PubMed Web of Science ®Google Scholar
• Steindl G, Liu Y-L, Schmid D, et al. Epidemiology of invasive meningococcal disease in Austria 2010. Wien Klin Wochenschr. 2011;123(suppl 1):10–14.
   PubMed Web of Science ®Google Scholar
• Agier L, Deroubaix A, Martiny N, et al. Seasonality of meningitis in Africa and climate forcing: aerosols stand out. J R Soc Interface. 2013;10:20120814.
   PubMed Web of Science ®Google Scholar
• Mainassara HB, Sidikou F, Djibo S, et al. Epidemiological patterns of bacterial meningitis in Niger from 2002 to 2010. Sci J Public Health. 2014;2:58–63.
   Google Scholar
• Pérez García-Pando C, Stanton MC, Diggle PJ, et al. Soil dust aerosols and wind as predictors of seasonal meningitis incidence in Niger. Environ Health Perspect. 2014;122(7):679–686.
   PubMed Web of Science ®Google Scholar
• Jensen ES, Lundbye-Christensen S, Samuelsson S, et al. A 20-year ecological study of the temporal association between influenza and meningococcal disease. Eur J Epidemiol. 2004;19(2):181–187.
   PubMed Web of Science ®Google Scholar
• Fisman DN. Seasonality of infectious diseases. Annu Rev Public Health. 2007;28:127–143.
   PubMed Web of Science ®Google Scholar
• Dwilow R, Fanella S. Invasive meningococcal disease in the 21st century—an update for the clinician. Curr Neurol Neurosci Rep. 2015;15(3):2.
   PubMed Web of Science ®Google Scholar
• Leone G, Pizzigallo E. Bacterial infections following splenectomy for malignant and nonmalignant hematologic diseases. Mediterr J Hematol Infect Dis. 2015;7(1):e2015057.
   PubMed Web of Science ®Google Scholar
• Ram S, Lewis LA, Rice PA. Infections of people with complement deficiencies and patients who have undergone splenectomy. Clin Microbiol Rev. 2010;23:740–780.
   PubMed Web of Science ®Google Scholar
• Grimnes G, Beckman H, Lappegård KT, et al. Recurrent meningococcal sepsis in a presumptive immunocompetent host shown to be complement C5 deficient-a case report. Apmis. 2011;119(7):479–484.
   PubMed Web of Science ®Google Scholar
• Miller EC, Chase NM, Densen P, et al. Autoantibody stabilization of the classical pathway C3 convertase leading to C3 deficiency and neisserial sepsis: c4 nephritic factor revisited. Clin Immunol. 2012;145:241–250.
   PubMed Web of Science ®Google Scholar
• Dellepiane RM, Dell’Era L, Pavesi P, et al. Invasive meningococcal disease in three siblings with hereditary deficiency of the 8(th) component of complement: evidence for the importance of an early diagnosis. Orphanet J Rare Dis. 2016;11(1):64.
   PubMed Web of Science ®Google Scholar
• Bathum L, Hansen H, Teisner B, et al. Association between combined properdin and mannose-binding lectin deficiency and infection with Neisseria meningitidis. Mol Immunol. 2006;43:473–479.
   PubMed Web of Science ®Google Scholar
• Briassoulis G, Galani A. Prognostic markers of pediatric meningococcal sepsis. Expert Rev Anti Infect Ther. 2014;12(9):1017–1020.
   PubMed Web of Science ®Google Scholar
• Hellenbrand W, Koch J, Harder T, et al. Background Paper for the update of meningococcal vaccination recommendations in Germany: use of the serogroup B vaccine in persons at increased risk for meningococcal disease. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015;58(11–12):1314–1343.
   PubMed Web of Science ®Google Scholar
• Esposito S, Bosis S, Orenti A, et al. Genetic polymorphisms and the development of invasive bacterial infections in children. Int J Immunopathol Pharmacol. 2016;29(1):99–104.
   PubMed Web of Science ®Google Scholar
• Salit IE. Meningococcemia caused by serogroup W135. Association with hypogammaglobulinemia. Arch Intern Med. 1981;141(5):664–665.
   PubMedGoogle Scholar
• COMMITTEE ON INFECTIOUS DISEASES. Recommendations for serogroup B meningococcal vaccine for persons 10 years and older. Pediatrics. 2016+;138(3):e20161890–e20161890.
   Web of Science ®Google Scholar
• Hibberd ML, Sumiya M, Summerfield JA, et al. Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Lancet. 1999;353:1049–1053.
   PubMed Web of Science ®Google Scholar
• Fijen CA, Bredius RG, Kuijper EJ, et al. The role of Fc gamma receptor polymorphisms and C3 in the immune defense against Neisseria meningitidis in complement-deficient individuals. Clin Exp Immunol. 2000;120:338–345.
   PubMed Web of Science ®Google Scholar
• Emonts M, Hazelzet JA, De Groot R, et al. Host genetic determinants of Neisseria meningitidis infections. Lancet Infect Dis. 2003;3:565–577.
   PubMed Web of Science ®Google Scholar
• Cohn AC, MacNeil JR, Harrison LH, et al. Changes in Neisseria meningitidis disease epidemiology in the United States, 1998–2007: implications for prevention of meningococcal disease. Clin Infect Dis. 2010;50:184–191.
   PubMed Web of Science ®Google Scholar
• Cohn A, MacNeil J. The changing epidemiology of meningococcal disease. Infect Dis Clin N Am. 2015;29:667–677.
   PubMed Web of Science ®Google Scholar
• Cohen C, Singh E, Wu HM, et al. Increased incidence of meningococcal disease in HIV-infected individuals associated with higher case-fatality ratios in South Africa. Aids. 2010;24(9):1351–1360.
   PubMed Web of Science ®Google Scholar
• Miller L, Arakaki L, Ramautar A, et al. Elevated risk for invasive meningococcal disease among persons with HIV. Ann Intern Med. 2014;160(1):30–37.
   PubMed Web of Science ®Google Scholar
• Simmons RD, Kirwan P, Beebeejaun K, et al. Risk of invasive meningococcal disease in children and adults with HIV in England: a population-based cohort study. BMC Med. 2015;13:297.
   PubMed Web of Science ®Google Scholar
• Struijk GH, Bouts AH, Rijkers G, et al. Meningococcal sepsis complicating eculizumab treatment despite prior vaccination. Am J Transplant. 2013;13(3):819–820.
   PubMed Web of Science ®Google Scholar
• Benamu E, Montoya JG. Infections associated with the use of eculizumab: recommendations for prevention and prophylaxis. Curr Opin Infect Dis. 2016;29(4):319–329.
   PubMed Web of Science ®Google Scholar
• Sejvar JJ, Johnson D, Popovic T, et al. Assessing the risk of laboratory-acquired meningococcal disease. J Clin Microbiol. 2005;43:4811–4814.
   PubMed Web of Science ®Google Scholar
• Deutch S, Labouriau R, Schønheyeder HC, et al. Crowding as a risk factor of meningococcal disease in Danish preschool children: a nationwide population-based case-control study. Scand J Infect Dis. 2004;36(1):20–23.
   PubMed Web of Science ®Google Scholar
• Ferraro CF, Trotter CL, Nascimento MC, et al. Household crowding, social mixing patterns and respiratory symptoms in seven countries of the African meningitis belt. Plos One. 2014;9(7):e101129.
   PubMed Web of Science ®Google Scholar
• Arsić B. Epidemics of meningitis in the Yugoslav Army and Yugoslav Militia during 1924-1974. Zb Vojnomed Akad. 1974;25–32.
   PubMedGoogle Scholar
• Biselli R, Fattorossi A, Matricardi PM, et al. Dramatic reduction of meningococcal meningitis among military recruits in Italy after introduction of specific vaccination. Vaccine. 1993;11(5):578–581.
   PubMed Web of Science ®Google Scholar
• Bergman BP, Hayton JC, Green AD. Effectiveness of the meningococcal vaccination programme for British Armed Forces recruits. Commun Dis Public Health. 2000;3(4):298–299.
   PubMedGoogle Scholar
• Jo YM, Bae SM, Kang YH. Cluster of serogroup W-135 meningococcal disease in 3 military recruits. J Korean Med Sci. 2015;30(5):662–665.
   PubMed Web of Science ®Google Scholar
• Bruce MG, Rosenstein NE, Capparella JM, et al. Risk factors for meningococcal disease in college students. Jama. 2001;286:688–693.
   PubMed Web of Science ®Google Scholar
• Mandal S, Wu HM, MacNeil JR, et al. Prolonged university outbreak of meningococcal disease associated with a serogroup B strain rarely seen in the United States. Clin Infect Dis. 2013;57(3):344–348.
   PubMed Web of Science ®Google Scholar
• Soeters HM, McNamara LA, Whaley M, et al. Serogroup B meningococcal disease outbreak and carriage evaluation at a college - Rhode Island, 2015. MMWR Morb Mortal Wkly Rep. 2015;64(22):606–607.
   PubMed Web of Science ®Google Scholar
• Basta NE, Mahmoud AA, Wolfson J, et al. Immunogenicity of a meningococcal B vaccine during a university outbreak. N Engl J Med. 2016;375(3):220–228.
   PubMed Web of Science ®Google Scholar
• Biswas HH, Han GS, Wendorf K, et al. Notes from the field: outbreak of serogroup B meningococcal disease at a university - California, 2016. MMWR Morb Mortal Wkly Rep. 2016;65(20):520–521.
   PubMed Web of Science ®Google Scholar
• McNamara LA, Shumate AM, Johnsen P, et al. First use of a serogroup b meningococcal vaccine in the US in response to a university outbreak. Pediatrics. 2015;135:798–804.
   PubMed Web of Science ®Google Scholar
• Harrison LH, Dwyer DM, Maples CT, et al. Risk of meningococcal infection in college students. JAMA. 1999;281:1906–1910.
   PubMed Web of Science ®Google Scholar
• Jackson LA, Wenger JD. Laboratory-based surveillance for meningococcal disease in selected areas, United States, 1989-1991. MMWR CDC Surveill Summ. 1993;42:21–30.
   PubMedGoogle Scholar
• Froeschle JE. Meningococcal disease in college students. Clin Infect Dis. 1999;29:215–216.
   PubMed Web of Science ®Google Scholar
• Castel AD, Reed G, Davenport MG, et al. College and university compliance with a required meningococcal vaccination law. J Am Coll Health. 2007;56(2):119–127.
   PubMed Web of Science ®Google Scholar
• Imrey PB, Jackson LA, Ludwinski PH, et al. Outbreak of serogroup C meningococcal disease associated with campus bar patronage. Am J Epidemiol. 1996;143:624–630.
   PubMed Web of Science ®Google Scholar
• Fischer M, Hedberg K, Cardosi P, et al. Tobacco smoke as a risk factor for meningococcal disease. Pediatr Infect Dis J. 1997;16:979–983.
   PubMed Web of Science ®Google Scholar
• Folaranmi T, Rubin L, Martin SW, et al. Use of serogroup B meningococcal vaccines in persons aged ≥10 years at increased risk for serogroup B meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2015. MMWR Morb Mortal Wkly Rep. 2015;64:608–612.
   PubMed Web of Science ®Google Scholar
• Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6003a3.htm
   Google Scholar
• Hassan-King MK, Wall RA, Greenwood BM. Meningococcal carriage, meningococcal disease and vaccination. J Infect. 1988;16(1):55–59.
   PubMed Web of Science ®Google Scholar
• Sáfadi MA, Carvalhanas TR, Paula De Lemos A, et al. Carriage rate and effects of vaccination after outbreaks of serogroup C meningococcal disease, Brazil, 2010. Emerg Infect Dis. 2014;20:806–811.
   PubMed Web of Science ®Google Scholar
• Trotter CL, Ramsay ME, Kaczmarski EB. Meningococcal serogroup C conjugate vaccination in England and Wales: coverage and initial impact of the campaign. Commun Dis Public Health. 2002;5(3):220–225.
   PubMedGoogle Scholar
• Maiden MC, Ibarz-Pavón AB, Urwin R, et al. Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity. J Infect Dis. 2008;197(5):737–743.
   PubMed Web of Science ®Google Scholar
• Kristiansen PA, Ba AK, Ouédraogo AS, et al. Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugated vaccine, MenAfriVac. BMC Infect Dis. 2014;14:663.
   PubMed Web of Science ®Google Scholar
• Gamougam K, Daugla DM, Toralta J, et al. Continuing effectiveness of serogroup A meningococcal conjugate vaccine, Chad, 2013. Emerg Infect Dis. 2015;21(1):115–118.
   PubMed Web of Science ®Google Scholar
• Collard JM, Issaka B, Zaneidou M, et al. Epidemiological changes in meningococcal meningitis in Niger from 2008 to 2011 and the impact of vaccination. BMC Infect Dis. 2013;13:576.
   PubMed Web of Science ®Google Scholar
• Finne J, Bitter-Suermann D, Goridis C, et al. An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues. J Immunol. 1987;138:4402–4407.
   PubMed Web of Science ®Google Scholar
• Sadarangani M, Pollard AJ. Serogroup B meningococcal vaccines-an unfinished story. Lancet Infect Dis. 2010;10:112–124.
   PubMed Web of Science ®Google Scholar
• Caron F, Du Châtelet IP, Leroy JP, et al. From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak. Lancet Infect Dis. 2011;11:455–463.
   PubMed Web of Science ®Google Scholar
• Delbos V, Lemée L, Bénichou J, et al. Impact of MenBvac, an outer membrane vesicle (OMV) vaccine, on the meningococcal carriage. Vaccine. 2013;31(40):4416–4420.
   PubMed Web of Science ®Google Scholar
• Piccini G, Torelli A, Gianchecchi E, et al. Fighting Neisseria meningitidis: past and current vaccination strategies. Expert Rev Vaccines. 2016;27:1–15.
   Google Scholar
• Centers for Disease Control and Prevention. Vaccine information statements. Serogroup B meningococcal vaccines. Available from: http://www.cdc.gov/vaccines/hcp/vis/vis-statements/mening-serogroup.html]
   Google Scholar
• Sadarangani M, Pollard AJ. Can we control all-cause meningococcal disease in Europe? Clin Microbiol Infect. 2016;22:S103–S112. DOI:10.1016/j.cmi.2016.03.006
   PubMedGoogle Scholar
• Oviedo-Orta E, Ahmed S, Rappuoli R, et al. Prevention and control of meningococcal outbreaks: the emerging role of serogroup B meningococcal vaccines. Vaccine. 2015;33:3628–3635.
   PubMed Web of Science ®Google Scholar
• Yezli S, Wilder-Smith A, Bin Saeed AA. Carriage of Neisseria meningitidis in the Hajj and Umrah mass gatherings. Int J Infect Dis. 2016;47:65–70.
   PubMed Web of Science ®Google Scholar
• Memish ZA, Goubeaud A, Bröker M, et al. Invasive meningococcal disease and travel. J Infect Public Health. 2010;3(4):143–151.
   PubMedGoogle Scholar
• Ceyhan M, Celik M, Demir ET, et al. Acquisition of meningococcal serogroup W-135 carriage in Turkish Hajj pilgrims who had received the quadrivalent meningococcal polysaccharide vaccine. Clin Vaccine Immunol. 2013;20(1):66–68.
   PubMed Web of Science ®Google Scholar
• Metanat M, Sharifi-Mood B, Sanei-Moghaddam S, et al. Pharyngeal carriage rate of Neisseria meningitidis before and after the Hajj pilgrimage, in Zahedan (southeastern Iran), 2012. Turk J Med Sci. 2015;45(6):1317–1320.
   PubMed Web of Science ®Google Scholar
• Martinelli D, Fortunato F, Prato R. Estimates of the burden of meningococcal disease in Italy: implications for prevention and control. J Prev Med Hyg. 2015;56:E112–5.
   PubMedGoogle Scholar
• Germinario C, Tafuri S, Napoli C, et al. Young-adult carriers of Neisseria meningitidis in Puglia (Italy): will the pattern of circulating meningococci change following the introduction of meningococcal serogroup C conjugate vaccines? Hum Vaccin. 2010;6:1025–1027.
   PubMed Web of Science ®Google Scholar
• Stefanelli P, Miglietta A, Pezzotti P, et al. Increased incidence of invasive meningococcal disease of serogroup C /clonal complex 11, Tuscany, Italy, 2015 to 2016. Euro Surveill. 2016;21:12.
   PubMedGoogle Scholar
• Bonanni P, Ferro A, Guerra R, et al. Vaccine coverage in Italy and assessment of the 2012-2014 National Immunization Prevention Plan. Epidemiol Prev. 2015;39:146–158.
   PubMed Web of Science ®Google Scholar
• Laboratory methods for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenza. WHO manual. 2nd. 2011 Dec 01.
   Google Scholar
• Bryant PA, Li HY, Zaia A, et al. Prospective study of a real-time PCR that is highly sensitive, specific, and clinically useful for diagnosis of meningococcal disease in children. J Clin Microbiol. 2004;42:2919–2925.
   PubMed Web of Science ®Google Scholar
• Staquet P, Lemee L, Verdier E. Detection of Neisseria meningitidis DNA from skin lesion biopsy using real-time PCR: usefulness in the aetiological diagnosis of purpura fulminans. Intensive Care Med. 2007;33:1168–1172.
   PubMed Web of Science ®Google Scholar
• Parmentier L, Garzoni C, Antille C, et al. Value of a novel Neisseria meningitidis specific polymerase chain reaction assay in skin biopsy specimens as a diagnostic tool in chronic meningococcemia. Arch Dermatol. 2008;144:770–773.
   PubMedGoogle Scholar
• Mameli C, Galli E, Mantegazza C, et al. The multicomponent meningococcal serogroup B vaccine (4CMenB): origin, composition, health impact and unknown aspects. Future Microbiol. 2015;10:1579–1598.
   PubMed Web of Science ®Google Scholar
• Stefanelli P, Rezza G. Impact of vaccination on meningococcal epidemiology. Hum Vaccin Immunother. 2016;12(4):1051–1055.
   PubMed Web of Science ®Google Scholar
• Kristiansen PA, Ba AK, Sanou I, et al. Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine. BMC Infect Dis. 2013;13:363.
   PubMed Web of Science ®Google Scholar
• Kristiansen PA, Diomandé F, Ba AK, et al. Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity. Clin Infect Dis. 2013;56(3):354–363.
   PubMed Web of Science ®Google Scholar
• Trotter CL, McVernon J, Ramsay ME, et al. Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae. Vaccine. 2008;26:4434–4445.
   PubMed Web of Science ®Google Scholar
• Boisier P, Nicolas P, Djibo S, et al. Carriage of Neisseria meningitidis serogroup W135 ST-2881. Emerg Infect Dis. 2006;12:1421–1423.
   PubMed Web of Science ®Google Scholar
• Korzeniewski K, Skoczyńska A, Guzek A, et al. Effectiveness of immunoprophylaxis in suppressing carriage of Neisseria meningitidis in the military environment. Adv Exp Med Biol. 2015;836:19–28.
   PubMed Web of Science ®Google Scholar
• Anderson AS, Hao L, Jiang Q, et al. Potential impact of the bivalent rLP2806 vaccine on Neisseria meningitidis carriage and invasive serogroup B disease. Hum Vaccin Immunother. 2013;9(3):471–479.
   PubMed Web of Science ®Google Scholar
• Vetter V, Baxter R, Denizer G, et al. Routinely vaccinating adolescents against meningococcus: targeting transmission & disease. Expert Rev Vaccines. 2016;15:641–658.
   PubMed Web of Science ®Google Scholar
• Manigart O, Okeakpu J, Odutola A, et al. Alternative molecular methods for improved detection of meningococcal carriage and measurement of bacterial density. J Clin Microbiol. 2016;54(11):2743–2748.
   PubMed Web of Science ®Google Scholar